Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling

被引:88
作者
Castro, Michele M.
Rizzi, Elen
Prado, Cibele M. [2 ]
Rossi, Marcos A. [2 ]
Tanus-Santos, Jose E. [1 ]
Gerlach, Raquel Fernanda [3 ]
机构
[1] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pharmacol, BR-14049900 Ribeirao Preto, SP, Brazil
[2] Fac Med Ribeirao Preto, Dept Pathol, Ribeirao Preto, Brazil
[3] Univ Sao Paulo, Dent Sch Ribeirao Preto, Dept Morphol Estomatol & Physiol, BR-14040904 Ribeirao Preto, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Hypertension; Matrix metalloproteinases; MMPs; Tissue inhibitor of metalloproteinases; TIMPs; Vascular remodeling; SMOOTH-MUSCLE-CELLS; INCREASED EXPRESSION; NEOINTIMA FORMATION; ANGIOTENSIN-II; LOCALIZATION; DYSFUNCTION; DEFICIENCY; MECHANISMS; MOLECULES; MIGRATION;
D O I
10.1016/j.matbio.2009.11.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Structural vascular changes in two-kidney, one-clip (2K-1C) hypertension may result from increased matrix metalloproteinase (MMP)-2 activity. MMP-2 activation is regulated by other MMPs, including transmembrane-MMPs, and by tissue inhibitors of MMPs (TIMPs). We have investigated the localization of MMP-2, -9, -14, and TIMPs 1-4 in hypertensive aortas and measured their levels by zymography/Western blotting and immunohistochemistry. Gelatinolytic activity was assayed in tissues by in situ zymography. Sham-operated and 2K-1C hypertensive rats were treated with doxycycline (or vehicle) for 8 weeks, and the systolic blood pressure was monitored weekly. Doxycycline attenuated 2K-1C hypertension (165 +/- 11.7 mmHg versus 213 +/- 7.9 mm Hg in hypertensive controls, P<0.01), and completely prevented increase in the thicknesses of the media and the intima in 2K-1C animals (P<0.01). Increased amounts of MMP-2, -9, and -14 were found in hypertensive aortas, as well as enhanced gelatinolytic activity. A gradient in the localization of MMP-2, -9, and -14 was found, with increased amounts detected in the intima, at sites with higher gelatinolytic activity. Doxycycline attenuated hypertension induced increases in all the 3 investigated MMPs in both the media and the intima (all P<0.05). but it did not change the amounts of TIMPs 1-4 (P>0.05). Therefore, an imbalance between increased amounts of MMPs at the tissue level without a corresponding increase in the quantities of TIMPs, particularly in the intima and inner media layers, appears to account for the increased proteolytic activity found in 2K-1C hypertension-induced maladaptive vascular remodeling. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:194 / 201
页数:8
相关论文
共 44 条
  • [1] Matrix metalloproteinases/tissue inhibitors of metalloproteinases - Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease
    Ahmed, SH
    Clark, LL
    Pennington, WR
    Webb, CS
    Bonnema, DD
    Leonardi, AH
    McClure, CD
    Spinale, FG
    Zile, MR
    [J]. CIRCULATION, 2006, 113 (17) : 2089 - 2096
  • [2] Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition
    Bouvet, C
    Gilbert, LA
    Girardot, D
    deBlois, D
    Moreau, P
    [J]. HYPERTENSION, 2005, 45 (03) : 432 - 437
  • [3] Tissue inhibitors of metalloproteinases: evolution, structure and function
    Brew, K
    Dinakarpandian, D
    Nagase, H
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2): : 267 - 283
  • [4] Angiotensin II increases tissue-specific inhibitor of metalloproteinase-2 expression in rat aortic smooth muscle cells in vivo:: Evidence of a pressure-independent effect
    Castoldi, G.
    di Gioia, C. R. T.
    Travaglini, C.
    Busca, G.
    Redaelli, S.
    Bombardi, C.
    Stella, A.
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2007, 34 (03) : 205 - 209
  • [5] ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo
    Castoldi, G
    di Gioia, CRT
    Pieruzzi, F
    D'Orlando, C
    van de Greef, WMM
    Busca, G
    Sperti, G
    Stella, A
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (02): : H635 - H643
  • [6] Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats
    Castro, Michele A.
    Rizzi, Elen
    Figueiredo-Lopes, Livia
    Fernandes, Karla
    Bendhack, Lusiane A.
    Pitol, Dimitrius Leonardo
    Gerlach, Raquel E.
    Tanus-Santos, Jose E.
    [J]. ATHEROSCLEROSIS, 2008, 198 (02) : 320 - 331
  • [7] Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension
    Castro, Michele M.
    Rizzi, Elen
    Rodrigues, Gerson J.
    Ceron, Carla S.
    Bendhack, Lusiane M.
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2009, 46 (09) : 1298 - 1307
  • [8] Pathways of matrix metalloproteinase induction in heart failure: Bioactive molecules and transcriptional regulation
    Deschamps, AM
    Spinale, FG
    [J]. CARDIOVASCULAR RESEARCH, 2006, 69 (03) : 666 - 676
  • [9] Individual Timp deficiencies differentially impact pro-MMP-2 activation
    English, JL
    Kassiri, Z
    Koskivirta, I
    Atkinson, SJ
    Di Grappa, M
    Soloway, PD
    Nagase, H
    Vuorio, E
    Murphy, G
    Khokha, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (15) : 10337 - 10346
  • [10] MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells
    Filippov, S
    Koenig, GC
    Chun, TH
    Hotary, KB
    Ota, I
    Bugge, TH
    Roberts, JD
    Fay, WP
    Birkedal-Hansen, H
    Holmbeck, K
    Sabeh, F
    Allen, ED
    Weiss, SJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (05) : 663 - 671